Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Visa, Bank of America, Salesforce, Zoom Video and CME Group

Read MoreHide Full Article

For Immediate Release

Chicago, IL – February 18, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Visa Inc. (V - Free Report) , Bank of America Corporation (BAC - Free Report) , salesforce.com, Inc. (CRM - Free Report) , Zoom Video Communications, Inc. (ZM - Free Report) and CME Group Inc. (CME - Free Report) .

Here are highlights from Wednesday’s Analyst Blog:

Top Stock Reports for Visa, Bank of America and salesforce.com

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa, Bank of America and salesforce.com. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Visa shares have modestly underperformed the Zacks Financial Transaction Services industry in the year-to- date period (-4.9% vs. -4.2%), reflecting the impact of restricted international travel on cross-border transactions. That sadi, the Zacks analyst believes that numerous acquisitions and alliances paved the way for long-term growth and consistently drove Visa’s revenues. Technological upgrades via investments also bode well for Visa.

The acquisition of Visa Europe is a strategic fit as well. The coronavirus vaccine development and the gradual revival of consumer confidence will drive spending, expanding the company's business volumes in turn.

A strong balance sheet enables investment in business. However, high operating expenses stress the operating margins. Ramped-up client initiatives will dent the top line. Also, a sluggish cross-border business due to the pandemic is a major concern.

(You can read the full research report on Visa here >>>)

Shares of Bank of America have gained +34.2% in the last six months against the Zacks Major Regional Banks industry’s gain of +39.9%, with the recent uptrend long-term interest rates helping the outlook for the bank as well as the group as a whole. The Zacks analyst believes that opening of new branches, improvement in digital offerings and efforts to manage costs are likely to aid the company’s profitability.

Also, a strong balance sheet and liquidity position are expected to continue aiding its financials. However, near-zero interest rates and no near-term chance of any change in the same are expected to keep hurting the bank’s margins and interest income.

Coronavirus-induced concerns are likely to further hamper business activities and thus, loan growth is expected to be muted in the near term. 

(You can read the full research report on Bank of America here >>>)

Salesforce shares have lost -3.3% over the past three months against the Zacks Computer Software industry’s rise of +14.1%, reflecting the market's skepticism about the Slack (WORK) transaction. The Zacks analyst is optimistic about the stock's long-term outlook and believes that the company is benefiting from a robust demand environment as customers are undergoing a major digital transformation.

The rapid adoption of its cloud-based solutions is driving demand for its products. The company’s sustained focus on introducing more aligned products as per customer needs is driving its top-line. Continued deal wins in the international market is another growth driver.

However, stiff competition is a concern. Besides, unfavorable currency fluctuations along with increasing investments in international expansions and data centers are an overhang on near-term profitability.

(You can read the full research report on salesforce here >>>)

Other noteworthy reports we are featuring today include Zoom Video and CME Group.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in